Suppr超能文献

催乳素刺激试验:产后妇女接受溴隐亭、利舒脲和麦角乙脲治疗后的不同反应模式。

Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.

作者信息

Bohnet H G, Kato K, De Moll H

机构信息

Institute for Hormone and Fertility Research, Hamburg, West Germany.

出版信息

Obstet Gynecol. 1988 Jan;71(1):53-5.

PMID:3336541
Abstract

To elucidate different mechanisms by which bromocriptine, lisuride, and metergoline may inhibit prolactin (PRL) secretion and lactation in puerperal women, the PRL secretion patterns were examined by means of a stimulation test using an intravenous bolus of metoclopramide. After seven and 14 days of treatment, no significant difference in basal serum PRL levels was observed. However, women subjected to metergoline treatment had significantly higher responses of PRL to metoclopramide as compared with those treated with either bromocriptine or lisuride. Thus, the PRL-lowering mechanism of metergoline appears to be different from those of bromocriptine and lisuride.

摘要

为阐明溴隐亭、利舒脲和麦角乙脲抑制产后妇女催乳素(PRL)分泌及泌乳的不同机制,采用静脉推注甲氧氯普胺刺激试验检测PRL分泌模式。治疗7天和14天后,基础血清PRL水平未见显著差异。然而,与接受溴隐亭或利舒脲治疗的妇女相比,接受麦角乙脲治疗的妇女对甲氧氯普胺的PRL反应显著更高。因此,麦角乙脲降低PRL的机制似乎与溴隐亭和利舒脲不同。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验